News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
646,773 Results
Type
Article (49492)
Company Profile (231)
Press Release (597036)
Multimedia
Podcasts (164)
Webinars (25)
Section
Business (178070)
Career Advice (2613)
Deals (32798)
Drug Delivery (139)
Drug Development (79569)
Employer Resources (169)
FDA (16625)
Job Trends (13756)
News (315764)
Policy (32771)
Tag
Academia (2435)
Academic (1)
Accelerated approval (30)
Adcomms (35)
Allergies (126)
Alliances (45129)
ALS (165)
Alzheimer's disease (1709)
Antibody-drug conjugate (ADC) (304)
Approvals (16764)
Artificial intelligence (490)
Autoimmune disease (134)
Automation (26)
Bankruptcy (330)
Best Places to Work (10203)
BIOSECURE Act (23)
Biosimilars (194)
Biotechnology (116)
Bladder cancer (149)
Brain cancer (55)
Breast cancer (582)
Cancer (4437)
Cardiovascular disease (386)
Career advice (2199)
Career pathing (40)
CAR-T (260)
CDC (59)
Cell therapy (709)
Cervical cancer (34)
Clinical research (67648)
Collaboration (1454)
Company closure (5)
Compensation (1075)
Complete response letters (64)
COVID-19 (2782)
CRISPR (82)
C-suite (693)
Cystic fibrosis (137)
Data (5646)
Decentralized trials (2)
Denatured (47)
Depression (128)
Diabetes (462)
Diagnostics (5887)
Digital health (36)
Diversity (11)
Diversity, equity & inclusion (43)
Drug discovery (228)
Drug pricing (205)
Drug shortages (35)
Duchenne muscular dystrophy (223)
Earnings (73700)
Editorial (60)
Employer branding (20)
Employer resources (151)
Events (99593)
Executive appointments (927)
FDA (19465)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (7)
Frontotemporal dementia (17)
Funding (1262)
Gene editing (182)
Generative AI (44)
Gene therapy (576)
GLP-1 (1059)
Government (4335)
Grass and pollen (8)
Guidances (372)
Healthcare (16099)
HIV (53)
Huntington's disease (45)
IgA nephropathy (80)
Immunology and inflammation (269)
Immuno-oncology (41)
Indications (77)
Infectious disease (3033)
Inflammatory bowel disease (187)
Inflation Reduction Act (14)
Influenza (103)
Intellectual property (214)
Interviews (479)
IPO (15497)
IRA (57)
Job creations (3877)
Job search strategy (1821)
Kidney cancer (16)
Labor market (78)
Layoffs (622)
Leadership (39)
Legal (7931)
Liver cancer (91)
Longevity (13)
Lung cancer (611)
Lymphoma (350)
Machine learning (36)
Management (59)
Manufacturing (702)
MASH (164)
Medical device (11918)
Medtech (11953)
Mergers & acquisitions (18271)
Metabolic disorders (1256)
Multiple sclerosis (150)
NASH (23)
Neurodegenerative disease (299)
Neuropsychiatric disorders (84)
Neuroscience (2868)
NextGen: Class of 2025 (5540)
Non-profit (3460)
Now hiring (51)
Obesity (617)
Opinion (311)
Ovarian cancer (141)
Pain (182)
Pancreatic cancer (196)
Parkinson's disease (269)
Partnered (28)
Patents (453)
Patient recruitment (404)
Peanut (54)
People (53819)
Pharmaceutical (89)
Pharmacy benefit managers (30)
Phase I (20871)
Phase II (29377)
Phase III (22890)
Pipeline (3948)
Policy (320)
Postmarket research (2613)
Preclinical (8526)
Press Release (50)
Prostate cancer (225)
Psychedelics (52)
Radiopharmaceuticals (265)
Rare diseases (793)
Real estate (5458)
Recruiting (69)
Regulatory (24650)
Reports (42)
Research institute (2281)
Resumes & cover letters (429)
Rett syndrome (23)
RNA editing (14)
RSV (73)
Schizophrenia (149)
Series A (220)
Series B (162)
Service/supplier (14)
Sickle cell disease (98)
Special edition (26)
Spinal muscular atrophy (162)
Sponsored (45)
Startups (3375)
State (2)
Stomach cancer (19)
Supply chain (105)
Tariffs (97)
The Weekly (115)
Vaccines (1066)
Venture capital (79)
Weight loss (438)
Women's health (63)
Worklife (21)
Date
Last 7 days (223)
Last 30 days (1939)
Last 365 days (30192)
2025 (30117)
2024 (33910)
2023 (37973)
2022 (48623)
2021 (52398)
2020 (49774)
2019 (40610)
2018 (31004)
2017 (31308)
2016 (30111)
2015 (33776)
2014 (27447)
2013 (23079)
2012 (24736)
2011 (25346)
2010 (23294)
Location
Africa (802)
Alabama (68)
Alaska (7)
Arizona (237)
Arkansas (12)
Asia (40296)
Australia (6660)
California (10098)
Canada (2744)
China (990)
Colorado (421)
Connecticut (462)
Delaware (314)
Europe (91213)
Florida (1515)
Georgia (306)
Hawaii (3)
Idaho (47)
Illinois (739)
India (56)
Indiana (441)
Iowa (20)
Japan (388)
Kansas (108)
Kentucky (34)
Louisiana (21)
Maine (74)
Maryland (1288)
Massachusetts (7446)
Michigan (258)
Minnesota (554)
Mississippi (5)
Missouri (110)
Montana (20)
Nebraska (24)
Nevada (110)
New Hampshire (62)
New Jersey (2790)
New Mexico (26)
New York (2668)
North Carolina (1364)
North Dakota (7)
Northern California (4887)
Ohio (271)
Oklahoma (16)
Oregon (35)
Pennsylvania (2006)
Puerto Rico (17)
Rhode Island (36)
South America (1170)
South Carolina (57)
South Dakota (1)
Southern California (3923)
Tennessee (151)
Texas (1509)
United States (36021)
Utah (261)
Virginia (247)
Washington D.C. (78)
Washington State (823)
West Virginia (4)
Wisconsin (97)
Wyoming (2)
646,773 Results for "zealand pharma a s".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Weight loss
Zealand Bets up to $2.5B in Metabolic Pact With Chinese Biotech
Also on Thursday, Zealand held its Capital Markets Day in London,
outlining the strategy
for its weight management franchise in the near-term, including launching five products by 2030.
December 11, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Zealand Pharma to participate in the 2025 Jefferies Global Healthcare Conference
November 13, 2025
·
1 min read
Obesity
Zealand Freezes Mid-Stage Obesity Asset To Focus on More Differentiated Drugs
The decision to pause dapiglutide will help Zealand focus investment into assets that have “the greatest potential for clinical differentiation” in obesity.
November 13, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Zealand Pharma Announces Financial Results for the First Nine Months of 2025
November 13, 2025
·
10 min read
Press Releases
Zealand Pharma and OTR Therapeutics enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases
December 11, 2025
·
5 min read
Press Releases
OTR Therapeutics and Zealand Pharma enter multi-program strategic collaboration and license agreement to develop novel therapeutics for metabolic diseases
December 11, 2025
·
4 min read
Obesity
Zealand’s GLP-1/GLP-2 Drug Elicits Over 11% Weight-Loss—With the Potential for More
Analysts at William Blair say dapiglutide’s 11.6% weight reduction at 28 weeks could still be better, given that Zealand’s study predominantly included men and enrolled patients with lower BMI at baseline.
June 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Zealand Pharma conference call on November 13 at 2pm CET (8am ET) to present third quarter 2025 financial results
November 7, 2025
·
1 min read
Press Releases
Zealand Pharma to participate in upcoming investor conferences in September 2025
August 29, 2025
·
2 min read
Press Releases
Zealand Pharma appoints Rachel James-Owens as Vice President, Corporate Communications & Media Relations
September 25, 2025
·
5 min read
1 of 64,678
Next
